| |
| |
|
| Insider
Information: |
Green David |
| Relationship: |
Interim CEO, Director |
| City: |
Holliston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,084,432 |
|
|
Indirect Shares
|
251,364 |
|
|
| Direct
Value |
$3,506,243 |
|
|
|
Indirect Value
|
$834,503 |
|
|
| Total
Shares |
1,335,796 |
|
|
| Total
Value |
$4,340,746 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 49.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harvard Bioscience Inc |
HBIO |
Director |
2017-02-07 |
925,571 |
2017-02-07 |
234,896 |
Premium* |
|
|
Biostage Inc |
BSTG |
Interim CEO, Director |
2022-05-12 |
158,861 |
2022-05-12 |
16,468 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
136 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HBIO |
Harvard Bioscience Inc |
President |
• • – |
2011-03-30 |
4 |
AS |
$6.08 |
$226,769 |
D/D |
(37,300) |
1,485,302 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2015-04-20 |
4 |
S |
$6.31 |
$152,172 |
D/D |
(24,116) |
747,634 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2015-04-21 |
4 |
S |
$6.33 |
$338,104 |
D/D |
(53,413) |
694,221 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2015-04-17 |
4 |
S |
$6.49 |
$35,695 |
D/D |
(5,500) |
771,750 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2015-04-15 |
4 |
S |
$6.53 |
$102,521 |
D/D |
(15,700) |
798,553 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2015-04-13 |
4 |
S |
$6.56 |
$155,472 |
D/D |
(23,700) |
841,385 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2015-04-14 |
4 |
S |
$6.57 |
$178,257 |
D/D |
(27,132) |
814,253 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2015-04-16 |
4 |
S |
$6.59 |
$140,387 |
D/D |
(21,303) |
777,250 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2015-04-10 |
4 |
S |
$6.68 |
$195,964 |
D/D |
(29,336) |
865,085 |
0 |
- |
|
| BSTG |
Biostage Inc |
Chief Executive Officer |
• • – |
2014-03-17 |
4 |
OE |
$8.20 |
$100,540 |
D/D |
12,261 |
347,663 |
0 |
- |
|
| BSTG |
Biostage Inc |
Chief Executive Officer |
• • – |
2014-03-17 |
4 |
D |
$10.69 |
$100,529 |
D/D |
(9,404) |
338,259 |
0 |
- |
|
136 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
